Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
Diabetes Technology & Therapeutics coverage includes:
Detection and prevention of long-term micro- and macrovascular complications
Breakthrough technologies and new therapeutic drug classes
Behavioral aspects and approaches to diabetes care
The latest advancement and applications of new and emerging technologies, including:
Alternate insulin delivery methods
Continuous glucose monitoring
Artificial pancreas
Computerized case management/telemedicine
New insulins with ultra-rapid onset of action
Detection and prevention of hypoglycemia
Diabetes Technology & Therapeutics is under the editorial leadership of Editor-in-Chief Satish K. Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes; Senior Editors Jay S. Skyler, MD, MACP, University of Miami Miller School of Medicine, and Irl B. Hirsch, MD, University of Washington Medical Center–Roosevelt; and other leading investigators.
Audience: Endocrinologists, pediatricians, family practice physicians, nurse practitioners, diabetes clinics, and diabetes equipment manufacturers, among others